Department of Microbiology, Colorado State University, 200 West Lake Street, Ft Collins, CO 80523, USA
Correspondence
Elizabeth Hunsperger
enh4{at}cdc.gov
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Present address: Centers for Disease Control and Prevention (CDC), National Center for Infectious Diseases, Division of Vector-Borne Infectious Diseases, PO Box 2087, Foothills Campus, Ft Collins, CO 80522, USA
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In HSV-1 latently infected individuals, the observed reactivation following fever or severe burns suggests that noxious temperatures may induce a signalling mechanism leading to reactivation of latent virus. The receptor in the peripheral nervous system that responds to noxious heat stimulus is the capsaicin receptor, also known as the vanilloid receptor-1 (VR-1). VR-1 is an ion channel that preferentially fluxes calcium ions on activation and is primarily, but not exclusively, found on nociceptor neurons (Caterina et al., 2000; Mezey et al., 2000
). Nociceptors or pain-perceiving neurons exist at the dermal epithelial layer as free nerve endings, in contrast to other peripheral neurons that contain laminates of some form protecting the nerve endings in the tissue. Because the nociceptor is the only free nerve ending in the dermal epithelium, it may be more susceptible to virus uptake and more likely to harbour latent virus. The exposed free nerve terminal of the nociceptor responds primarily to painful stimuli including extreme heat, painful mechanical stimulus and noxious chemicals. Nociceptor neurons are not only sensitive to increases in temperature that exceed 45 °C but are also activated by the pungent extract from hot chilli peppers, capsaicin (Schmelz et al., 2000
). These stimuli, which activate the nociceptor, also cause HSV-1 reactivation.
To elucidate the signalling pathway involved in fever-induced HSV-1 reactivation, we examined the effects of heat-shock and capsaicin in an in vitro neuronal model of HSV-1 latency. This model allows the direct investigation of the signal transduction pathway specific for HSV-1 reactivation in sensory neurons in a defined and controlled environment (Wilcox & Johnson, 1987). Through immunocytochemistry, we found that the majority of neurons in the cultures were VR-1-positive. Our results, both with heat-shock and capsaicin treatment, indicated that VR-1 activation leads to reactivation of latent HSV-1 in sensory neurons. Additionally, reactivation through VR-1 activation could be attenuated with an antagonist to VR-1 or the calcium chelator, BAPTA. These results suggest that elevation of intracellular calcium induced by VR-1 activation regulates HSV-1 reactivation in neurons.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Establishment of latent HSV-1 infections.
Latent HSV-1 infections in neuronal cultures were established as previously described (Smith & Wilcox, 1996; Wilcox & Johnson, 1988
; Wilcox et al., 1990
). Briefly, after the neurons had been allowed to mature in tissue culture for 21 days, they were treated with 50 µM acycloguanosine (Sigma) 24 h prior to inoculation with HSV-1 and for the following 7 days after inoculation. Neuronal cultures were infected with approximately 10 p.f.u. HSV-1 (17+) per neuron (m.o.i.=10). The cells were incubated with the virus for 1 h and subsequently washed to remove any virus that did not absorb during the incubation period. In the presence of acycloguanosine, HSV-1 establishes a latent infection and can be detected as an episome in the nucleus (Wilcox et al., 1997
). Furthermore, we have previously observed the presence of LAT in the HSV-1 latently infected DRG cultures (Doerig et al., 1991
).
Reactivation of latent HSV-1.
Following the 14-day latent infection period, the cultures were reactivated with various stimuli. Reactivation stimuli for latent HSV-1 cultures included capsaicin treatment and heat shock. Capsaicin (Alexis Biochemicals) was diluted in the neuronal maintenance medium at concentrations ranging from 0·01 to 10 µM and incubated for 4 days prior to harvesting for plaque assays. For heat-shock treatments, the latently infected neurons were placed in a 4246 °C water bath for 15 min and transferred back to a 35 °C incubator for 4 days prior to harvesting the cells and medium for plaque assays. For VR-1 inhibition experiments, cultures were pretreated with the capsaicin receptor antagonist capsazepine (Alexis Biochemicals) at 10, 25 and 50 µM for 1 h prior to heat shock at 46 °C for 15 min. For forskolin-induced reactivation, the neurons were pretreated with either 50 µM capsazepine or 100 µM BAPTA-AM [1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetra(acetoxymethyl) ester] and subsequently reactivated with 100 µM forskolin.
Previous experiments characterizing the in vitro latency model have determined that infectious viral particles are present in the cell lysate at a minimum of 3 days following a reactivation stimulus and that maximum virus output occurs at 5 days post-reactivation stimulus, depending on the reactivation stimulus (Wilcox et al., 1990).
Because HSV-1 is cell-associated, assaying the cell extract and medium together was necessary in order to detect total infectious viral particles present following reactivation. For gentle release of infectious viral particles from the cells, the neurons were placed in a -70 °C freezer overnight. The neurons were subjected to a freezethaw cycle and the cell medium and extract were assayed for the presence of infectious virus. Neuronal cultures were harvested at the times indicated following the treatments indicated and plaque assays were performed. A standard plaque assay with Vero cells was used to determine infectious viral particles present following the reactivation stimuli. The results presented were from three independent experiments with six separate culture wells for each treatment group (n=6). The data were analysed by ANOVA with a TukeyKramer adjustment using SAS statistical software.
Plaque assay.
To determine infectious viral particles present in the cell extract and medium of the reactivated neurons, a standard plaque assay was performed. Vero cells were plated on to 24-well plates and grown to confluency. The growth medium was removed and an aliquot of 200 µl of the neuronal reactivated cell extract, at various dilutions, was incubated with the Vero cells for 1 h. Following incubation, the DRG cell extract was removed and a 1 % methylcellulose-containing medium was placed on the cells. Plaque formation occurred within 3 days of the initial infection. In order to visualize the plaques, the methylcellulose was removed and the cells were fixed and stained with 1 % crystal violet in methanol. Plaques were visualized under a light box and counted for each reactivated neuronal well.
Cell viability.
Cell viability was determined using AlamarBlue (BioSource Int.) colorimetric dye according to the manufacturer's protocol, which is based on an oxidationreduction reaction. The cells were incubated with capsaicin at 110 µM for 4 days and then treated with AlamarBlue for 3 h. Following AlamarBlue treatment, the medium was collected and read on a colorimetric plate reader at 550 and 600 nm. All treatment groups were compared with control (no treatment) and represented as a percentage of control cultures.
Immunocytochemistry.
Neuronal cultures were fixed in 4 % paraformaldehyde overnight at 4 °C. Following fixation, the cells were permeabilized with 0·2 % Triton X-100 (Sigma) and blocked with 5 % non-fat milk in PBS containing 0·5 % Tween 20 for 1 h. The cells were then incubated with capsaicin receptor primary polyclonal rabbit antibody (Ab-1) at a concentration of 0·1 µg µl-1 (Oncogene Research) overnight at 4 °C. Following primary antibody incubation, the cells were washed and incubated with a universal secondary IgG anti-rabbit antibody conjugated to horseradish peroxidase for 1 h, according to the manufacturer's protocol. Diaminobenzidine was used as the substrate (Vector Laboratories).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
|
|
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In our studies, heat, a potent agonist of the VR-1 channel, induced HSV-1 reactivation in vitro. In humans, stimuli associated with heat such as fever, sunburn and burns also correlate with HSV-1 reactivation (Boak et al., 1934; Bourdarias et al., 1996
). Based on these observations, animal models were developed utilizing heat shock as a method of inducing reactivation of latent HSV-1 (Epstein, 1941
; Moriya et al., 1994
; Sawtell & Thompson, 1992
). The mechanism of heat-induced reactivation of HSV-1 has not been elucidated but a possible model may involve overstimulation of the heat-sensitive neurons or nociceptors, inducing reactivation of latent HSV-1. Interestingly, there are no studies to date examining the signal transduction pathways of HSV-1 reactivation following stimulation of the heat-sensitive receptor, VR-1. Our data suggest that the mechanism of heat-induced reactivation involves the activation of VR-1, since the most robust reactivation occurred at the optimal temperature for VR-1 activation, 46 °C. Furthermore, this heat-induced virus reactivation could be significantly attenuated using an antagonist to VR-1, capsazepine. Although capsazepine has been utilized as a specific VR-1 antagonist, it also blocks voltage-activated calcium channels in DRG cultures (Docherty et al., 1997
).
Another potent agonist of VR-1 that also induces HSV-1 reactivation in the in vitro model is capsaicin, the active component in hot chilli peppers. Capsaicin has been previously tested as a treatment to alleviate the recurrence of herpetic lesions in an HSV-2 guinea pig latency model (Bourne et al., 1999; Stanberry, 1989
). Although these data indicate a slight decrease in herpetic lesions following primary infection and a decrease in immediate recurrence following capsaicin treatment, the animals became desensitized to the capsaicin treatment (Stanberry, 1989
). This implies that the nerve termini may have been damaged or destroyed following capsaicin treatment. In our latency model, VR-1 activation with capsaicin induced HSV-1 reactivation from latently infected neuronal cultures. Interestingly, capsaicin induced a bell-shaped dose-response curve with decreases in virus titre at higher concentrations of capsaicin that were not due to neuronal cell death, based on the viability assay. We attributed this decrease in reactivation to desensitization of VR-1 at higher doses of capsaicin, as previously observed in vivo (Bourne et al., 1999
; Stanberry, 1989
).
The desensitization of VR-1 at higher concentrations of capsaicin suggests a protective mechanism of the neuron to shut off damaging Ca2+ influxes. Other investigators have noted desensitization of VR-1 following repeated stimulation with capsaicin in electrophysiology experiments (Docherty et al., 1996; Koplas et al., 1997
; Piper et al., 1999
). In these experiments, repeated exposure to capsaicin decreased and eventually abolished calcium currents. Furthermore, other studies have noted a decrease in mRNA levels of VR-1 following capsaicin treatment, suggesting down-regulation of the receptor (Mezey et al., 2000
). The mechanism underlying this desensitization is unknown, although it has been suggested that capsaicin desensitization may be similar to calcium-dependent inactivation of the N-methyl D-aspartate receptor (Docherty et al., 1996
). This assumes that a particular threshold of intracellular Ca2+ levels negatively affects channel activity and gating (Koplas et al., 1997
). Because capsaicin treatment results in rapid VR-1 desensitization in electrophysiology experiments and long-term desensitization in animal models, there may be two components of this desensitization. One component may be attributed to multiple ligand binding domains within particular regions on the receptor that change the kinetics and gating properties of the channel. The second component may involve receptor turnover. These two components may regulate the internal calcium levels to ensure survival of the neuron.
The neuron relies on calcium channels and non-selective ion channels such as VR-1 to regulate intracellular calcium. Hence, VR-1 is found not only at the nerve terminal, but throughout the axon and soma (Guo et al., 1999). Additionally, the neuron expresses calcium-binding proteins capable of chelating excess toxic levels of calcium, preventing continuous stimulation and allowing cellular recovery (Berridge, 1998
). Prolonged Ca2+ increases due to a high-intensity stimulus, such as a pain stimulus, causes hyperexcitation of the neuron. This high-intensity stimulus causes a prolonged increase in intracellular Ca2+, creating a wave of calcium that eventually reaches the soma or cell body of the neuron (Usachev & Thayer, 1999
). In the in vitro model, this hyperexcitation may occur rapidly due to the fact that we are stimulating not only the nerve terminal but also the cell body. When hyperexcitation of a neuron occurs, these unusually elevated intracellular calcium levels in the soma transition the transcriptional machinery from a normal basal level to a highly active level (Buonanno & Fields, 1999
; West et al., 2001
). Perhaps in response to this increase in transcriptional activity in the neuron due to prolonged Ca2+ stimulation, HSV-1 is able to induce the transcription of immediate-early genes and begin a lytic infection. This may occur either via a direct role through Ca2+-dependent transcription factors or through an indirect activation of host-cell gene transcriptional machinery that serendipitously initiates HSV-1 transcription.
Interestingly, many of the reactivation stimuli tested in the in vitro model modulate VR-1 activation. For example, forskolin-induced HSV-1 reactivation is believed to involve the activation of PKA, which activates the VR-1 receptor (Lapshire & Nicol, 1998). In our experiments, the calcium chelator BAPTA reduced virus titres twofold following forskolin-induced reactivation compared with forskolin alone. These data imply that forskolin increases intracellular calcium, possibly by modulating VR-1 channel activity via phosphorylation ultimately resulting in HSV-1 reactivation. In addition, pretreatment with the VR-1 antagonist capsazepine, prior to forskolin treatment, attenuated and in some cases completely abolished HSV-1 reactivation. These data strongly suggest that forskolin modulates VR-1 gating properties and channel activity. Therefore, forskolin not only increases PKA levels that may be essential for the phosphorylation of important regulatory proteins involved with the initiation of transcription of HSV-1 immediate-early genes, but also regulates VR-1 activity critical for HSV-1 reactivation. These data further support the hypothesis that VR-1 receptor activation is the mechanism of forskolin-induced HSV-1 reactivation of latently infected neuronal cultures.
HSV-1 reactivation is a complex phenomenon that may involve multiple second messenger pathways. However, there may be a common target that funnels all the different stimuli for reactivation towards a common event of VR-1 activation. Previous studies have demonstrated that up-regulation of protein kinase C (PKC) and PKA caused reactivation of latent HSV-1 (Smith et al., 1992; Wilcox et al., 1990
). Activation of both of these kinases can directly affect VR-1 activity. Phorbol 12-myristate 13-acetate activates the second messenger PKC that directly stimulates sensory-specific sodium channels causing excitation of the neuron, induces HSV-1 reactivation and also activates VR-1 (Cesare et al., 1999
; Khasar et al., 1999
; Premkumar & Ahern, 2000
; Smith et al., 1992
; Vellani et al., 2001
). Additionally, excitation of a nociceptor via direct activation of VR-1 with heat or capsaicin causes depolarization and firing of the neuron (Caterina et al., 1997
). Here we have shown that treatment of latently infected neurons with capsaicin or heat shock also induces reactivation of HSV-1 latently infected neurons in culture. A common feature of all of these reactivation stimuli is hyperexcitation of the neuron resulting in elevated intracellular calcium caused by VR-1 activation.
In conclusion, overstimulation of a nociceptor neuron sufficient to activate VR-1 is critical for the induction of HSV-1 reactivation. Our data support the hypothesis that a pain stimulus sufficient to activate VR-1 may create the switch from a latent HSV-1 infection to reactivation.
![]() |
ACKNOWLEDGEMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Berridge, M. J. (1998). Neuronal calcium signaling. Neuron 21, 1326.[Medline]
Boak, R. A., Carpenter, C. M. & Warren, S. L. (1934). Symptomatic herpetic manifestations following artificially induced fevers. J Bacteriol 27, 8387.
Bourdarias, B., Perro, G., Cutillas, M., Castede, J. C., Lafon, M. E. & Sanchez, R. (1996). Herpes simplex virus infection in burned patients: epidemiology of 11 cases. Burns 22, 287290.[CrossRef][Medline]
Bourne, N., Bernstein, D. I. & Stanberry, L. (1999). Civamide (cis-capsaicin) for treatment of primary recurrent experimental genital herpes. Antimicrob Agents Chemother 43, 26852688.
Buonanno, A. & Fields, R. D. (1999). Gene regulation by patterned electrical activity during neural and skeletal muscle development. Curr Opin Neurobiol 9, 110120.[CrossRef][Medline]
Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D. & Julius, D. (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389, 816824.[CrossRef][Medline]
Caterina, M. J., Leffler, A., Malmberg, A. B., Martin, W. J., Trafton, J., Petersen-Zeitz, K. R., Koltzenburg, M., Basbaum, A. I. & Julius, D. (2000). Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288, 306313.
Cesare, P., Dekker, L. V., Sardeni, A., Parker, P. J. & McNaughton, P. (1999). Specific involvement of PKC-epsilon in sensitization of neuronal response to painful heat. Neuron 23, 617624.[Medline]
Cook, S. D. (1992). Herpes simplex virus in the eye. Br J Ophthalmol 76, 365366.[Medline]
De Petrocellis, L., Harrison, S., Bisogno, T. & 7 other authors (2001). The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 77, 16601663.[CrossRef][Medline]
Docherty, R. J., Yeats, J. C., Bevan, S. & Boddeke, H. W. G. M. (1996). Inhibition of calcineurin inhibits the desensitization of capsaicin-evoked currents in cultured dorsal root ganglion neurons from adult rats. Eur J Physiol 431, 828837.[CrossRef][Medline]
Docherty, R. J., Yeats, J. C. & Piper, A. S. (1997). Capsazepine block of voltage-activated calcium channels in adult dorsal root ganglion neurones in culture. Br J Pharmacol 121, 14611467.[Abstract]
Doerig, C., Pizer, L. I. & Wilcox, C. L. (1991). Detection of the latency-associated transcript in neuronal cultures during the latent infection with herpes simplex virus type 1. Virology 183, 423426.[Medline]
Epstein, N. N. (1941). Herpes simplex following artificial fever therapy. J Am Med Assoc 117, 13271330.
Guo, A., Vulchanova, L., Wang, J., Li, X. & Elde, R. (1999). Immunocytochemical localization of the vanilloid receptor 1 (VR-1): relationship to neuropeptide, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 11, 946958.[CrossRef][Medline]
Hill, T. J., Blyth, W. A. & Harbour, D. A. (1977). Trauma to the skin causes recurrence of herpes simplex in the mouse. J Gen Virol 39, 2128.
Jancso, N., Jansco-Gabor, A. & Szolesanyi, J. (1967). Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 31, 138151.[Medline]
Khasar, S. G., McCarter, G. & Levine, J. D. (1999). Epinephrine produces a -adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol 81, 11041112.
Koplas, P. A., Rosenberg, R. L. & Oxford, G. S. (1997). The role of calcium in the desensitization of capsaicin responses in rat dorsal root ganglion neurons. J Neurosci 17, 35253527.
Lapshire, J. C. & Nicol, G. D. (1998). The cAMP transduction cascade mediates the prostaglandin E2 enhancement of the capsaicin-elicited current in rat sensory neurons whole cell and single-channel studies. J Neurosci 18, 60816092.
Mezey, E., Toth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., Guo, A., Blumberg, P. M. & Szallas, A. (2000). Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A 97, 36553660.
Moriya, A., Yoshiki, A., Kita, M., Fushiki, S. & Imanishi, J. (1994). Heat shock-induced reactivation of herpes simplex virus type 1 in the latently infected mouse trigeminal ganglion cells in dissociated cultures. Arch Virol 135, 419425.[Medline]
Piper, A. S., Yeats, J. C., Bevan, S. & Docherty, R. J. (1999). A study of the voltage dependence of capsaicin-activated membrane currents in rat sensory neurones before and after acute desensitization. J Physiol 518, 721733.
Premkumar, L. S. & Ahern, G. P. (2000). Induction of vanilloid receptor channel activity by protein kinase C. Nature 408, 985990.[CrossRef][Medline]
Sawtell, N. M. & Thompson, R. L. (1992). Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol 66, 21502156.[Abstract]
Schmelz, M., Schmid, R., Handwerker, H. O. & Torebjork, H. E. (2000). Encoding of burning pain from capsaicin-treated human skin in two categories of unmylelinated nerve fibres. Brain 123, 560571.
Smith, R. & Wilcox, C. (1996). Studies of herpes simplex virus 1 latency using primary neuronal cultures of dorsal root ganglion neurons. In Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders, pp. 221231. Edited by P. R. Lowenstein & L. W. Enquist. West Sussex, UK: John Wiley & Sons.
Smith, R. L., Pizer, L. I., Johnson, E. M., Jr & Wilcox, C. L. (1992). Activation of second-messenger pathways reactivates latent herpes simplex virus in neuronal cultures. Virology 188, 311318.[Medline]
Stanberry, L. R. (1989). Capsaicin interferes with the centrifugal spread of virus in primary and recurrent genital herpes simplex virus infections. J Infect Dis 162, 2934.
Stevens, J. G., Wagner, E. K., Devi-Rao, G. B., Cook, M. L. & Feldman, L. T. (1987). RNA complimentary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235, 10561059.[Medline]
Usachev, Y. M. & Thayer, S. A. (1999). Controlling the urge for a Ca2+ surge: all-or-none Ca2+ release in neurons. Bioessays 21, 743750.[CrossRef][Medline]
Vellani, V., Mapplebeck, S., Moriondo, A., Davis, J. B. & McNaughton, P. A. (2001). Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol 534, 813825.
Wagner, E. K. & Bloom, D. C. (1997). Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev 10, 419443.[Abstract]
West, A. E., Chen, W. G., Dalva, M. B., Dolmetsch, R. E., Kornhauser, J. M., Shaywitz, A. J., Takasu, M. A., Tao, X. & Greenberg, M. E. (2001). Calcium regulation of neuronal gene expression. Proc Natl Acad Sci U S A 98, 1102411031.
Wilcox, C. L. & Johnson, E. M., Jr (1987). Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in latency neurons in vitro. J Virol 61, 23112315.[Medline]
Wilcox, C. L. & Johnson, E. M., Jr (1988). Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J Virol 62, 393399.[Medline]
Wilcox, C. L., Smith, R. L., Freed, C. R. & Johnson, E. M., Jr (1990). Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neurosci 10, 12681275.[Abstract]
Wilcox, C. L., Smith, R. L., Everett, R. D. & Mysofski, D. (1997). The herpes simplex virus type 1 immediate-early protein ICP0 is necessary for efficient establishment of latent infection. J Virol 71, 67776785.[Abstract]
Received 13 September 2002;
accepted 10 January 2003.
HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
J MED MICROBIOL | ALL SGM JOURNALS |